Kane Biotech Inc. (KNBIF)
OTCMKTS
· Delayed Price · Currency is USD
0.0667
0.00 (0.00%)
Apr 23, 2025, 4:00 PM EDT
Kane Biotech Revenue
Kane Biotech had revenue of 1.28M CAD in the quarter ending September 30, 2024, with 4,650.21% growth. This brings the company's revenue in the last twelve months to 2.01M, down -216.43% year-over-year. In the year 2023, Kane Biotech had annual revenue of 148.98K, down -4.95%.
Revenue (ttm)
2.01M CAD
Revenue Growth
-216.43%
P/S Ratio
7.11
Revenue / Employee
n/a
Employees
n/a
Market Cap
10.59M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 148.98K | -7.75K | -4.95% |
| Dec 31, 2022 | 156.73K | -1.45M | -90.25% |
| Dec 31, 2021 | 1.61M | 266.20K | 19.84% |
| Dec 31, 2020 | 1.34M | -351.95K | -20.78% |
| Dec 31, 2019 | 1.69M | 1.19M | 234.51% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.76B |
| SS Innovations International | 20.65M |
| Veradigm | 588.02M |
| Elite Pharmaceuticals | 70.00M |
| Northwest Biotherapeutics | 1.38M |
| Glass House Brands | 200.90M |
| BioStem Technologies | 301.83M |
| American Oncology Network | 1.76B |
Kane Biotech News
- 13 days ago - Kane Biotech Announces New Agreement with Outside the Box Capital Inc. - GlobeNewsWire
- 6 weeks ago - Kane Biotech Secures IRB Approval to Launch Innovative DispersinB® Acne Trial - GlobeNewsWire
- 6 weeks ago - Kane Biotech Announces Canadian Distribution Agreement With Best Buy Medical for revyve™ Antimicrobial Wound Gel - GlobeNewsWire
- 2 months ago - Kane Biotech Announces Second and Final Closing of Private Placement Offering - GlobeNewsWire
- 3 months ago - Kane Biotech Announces First Closing of Private Placement Offering and Extension of Private Placement Offering - GlobeNewsWire
- 5 months ago - Kane Biotech Inc (KNBIF) Q3 2024 Earnings Call Highlights: Revenue Surge and Strategic Milestones - GuruFocus
- 5 months ago - Q3 2024 Kane Biotech Inc Earnings Call Transcript - GuruFocus
- 5 months ago - Kane Biotech announces $3M private placement offering - Seeking Alpha